WITHDRAWN: Correlations of CTLA-4 exon-1 rs231775A>G and promoter region rs5742909C>T polymorphisms with the therapeutic efficacy of (131)I radionuclide in Graves' disease.

Luan S, Gao Y, Wang C, Pei CY, Zhao CJ

Open source

DOI
10.1042/bsr20170138
Published
2017 Jun 6
Container
Bioscience reports
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1042/bsr20170138,
  title = {WITHDRAWN: Correlations of CTLA-4 exon-1 rs231775A>G and promoter region rs5742909C>T polymorphisms with the therapeutic efficacy of (131)I radionuclide in Graves' disease.},
  author = {Luan S and Gao Y and Wang C and Pei CY and Zhao CJ},
  year = {2017},
  journal = {Bioscience reports},
  doi = {10.1042/bsr20170138},
  url = {https://doi.org/10.1042/bsr20170138}
}

RIS

TY  - JOUR
TI  - WITHDRAWN: Correlations of CTLA-4 exon-1 rs231775A>G and promoter region rs5742909C>T polymorphisms with the therapeutic efficacy of (131)I radionuclide in Graves' disease.
AU  - Luan S
AU  - Gao Y
AU  - Wang C
AU  - Pei CY
AU  - Zhao CJ
PY  - 2017
JO  - Bioscience reports
DO  - 10.1042/bsr20170138
UR  - https://doi.org/10.1042/bsr20170138
ER  - 

APA

S, L., Y, G., C, W., CY, P., & CJ, Z. (2017). WITHDRAWN: Correlations of CTLA-4 exon-1 rs231775A>G and promoter region rs5742909C>T polymorphisms with the therapeutic efficacy of (131)I radionuclide in Graves' disease.. Bioscience reports. https://doi.org/10.1042/bsr20170138

Source records